Ascentage Pharma

Developer of small molecules drugs for the treatment of cancers

placeHong Kong, Hong Kong, China calendar_todayFounded 2009 groups565 employees language ascentagepharma.com

Social engagement

Social engagement: 18.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

15 investors on record; lead investors include SDIC Innovation, Oriza Ventures, Yuan Ming Capital.

Investor typeCountShare
Venture capital533%
Private equity640%
Bank & private debt213%
Other / undisclosed213%

Recent activity

27 May 2026
Milestone
regulatory
25 May 2026
Event
ASCO 2026 Annual Meeting
13 May 2026
Event
31st Congress of the European Hematology Association (EHA2026)
Coming soon